Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Risky Research Review Act
Client: UNIVERSITY OF LOUISVILLE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to funding for university research opportunities via Fiscal Year 2025 and Fiscal Year 2026 Federal appropriations; Fiscal Year 2026 defense authorization bill; Issues related to Regional Biocontainment Laboratories (RBLs), cybersecurity, and military health; H.R. 1864 / S. 854 - Risky Research Review Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: FLETCHER GROUP, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
UNIVERSITY OF LOUISVILLE via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to funding for university research opportunities through Fiscal Year 2026 federal appropriations.
Issues related to military health and research; Issues related to cybersecurity; Issues related to defense innovation.
Source: Senate LDA
| SEPSIS STAKEHOLDER COALITION |
| 8 |
| 2018–2019 |
| ALLIANCE FOR AGING RESEARCH | 7 | 2024–2025 |
| ALKEUS PHARMACEUTICALS, INC. | 6 | 2024–2025 |
| AMERILIFE GROUP, LLC | 6 | 2024–2025 |
| INARI MEDICAL | 5 | 2021–2023 |
| OWENS & MINOR, INC. | 5 | 2020–2021 |
| PARTNERSHIP FOR MEDICAID HOME-BASED CARE | 5 | 2022–2024 |
| QNOVIA, INC. | 4 | 2023–2025 |
| Sight Sciences, Inc. | 4 | 2020–2021 |
| UNIVERSITY OF LOUISVILLE | 4 | 2024–2025 |
| 1-800 CONTACTS | 3 | 2021–2022 |
| BEECH TREE LABS, INC. | 3 | 2020 |
| BRADLEY LANE INVESTMENT COMPANY | 3 | 2022–2023 |
| COMMUNICARE | 3 | 2021 |
| FLETCHER GROUP INC. | 3 | 2024–2025 |
| FUJIFILM HOLDINGS AMERICA CORPORATION | 3 | 2023–2024 |
| Global Healthcare Exchange, LLC | 3 | 2020 |
| SENSEONICS INCORPORATED | 3 | 2021–2023 |
| BARRY THAGGARD MAY & BAILEY, LLP | 2 | 2020 |
| FINTHRIVE, INC. | 2 | 2022 |
| HOLLY HILL CHILDRENS HOME INC. | 2 | 2025 |
| SHATTERPROOF | 2 | 2024–2025 |
| SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) | 2 | 2021–2024 |
| TWENTY HOLDINGS INC | 2 | 2021 |
| CALOPTIMA | 1 | 2021 |
| ROTECH HEALTHCARE, INC. | 1 | 2020 |
| ResMed Corp. | 1 | 2023 |
| THE SPEED ART MUSEUM | 1 | 2025 |
| UOFL HEALTH, INC. | 1 | 2025 |
Issues related to substance use disorder; Issues related to recovery housing; Issues related to Medicaid; H.R. 2483/S. 2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025.
MAPS Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to advanced manufacturing, drug shortages, and pharmaceutical supply chains; Issues related to S.1784 - MAPS Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: FLETCHER GROUP, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to substance use disorder; Issues related to recovery housing; Issues related to Medicaid; H.R. 2483/S. 2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025.
Risky Research Review Act
Client: UNIVERSITY OF LOUISVILLE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to funding for university research opportunities via Fiscal Year 2025 and Fiscal Year 2026 Federal appropriations; Fiscal Year 2026 defense authorization bill; Issues related to Regional Biocontainment Laboratories (RBLs), cybersecurity, and military health; H.R. 1864 / S. 854 - Risky Research Review Act.
To amend title XVIII of the Social Security Act to require MA organizations offering network-based plans to maintain an accurate provider directory, and for other purposes.
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Substance Use Disorder programs; SUPPORT Act reauthorization; Issues related to behavioral health; H.R. 7708/S. 3059 - REAL Health Providers Act (118th Congress).
Issues related to Substance Use Disorder programs; SUPPORT Act reauthorization; Issues related to behavioral health; H.R. 7708/S. 3059 - REAL Health Providers Act (118th Congress).
Emergency Care Improvement Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Surprise billing; Telehealth; 1115 Medicaid Waiver; Health care workforce; Maternal health; Freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments (H.R. 2665 - The Supporting Safety Net Hospitals Act); Site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S. 2840 - Bipartisan Primary Care and Health Workforce Act); H.R. 3290 - 340B Drug Pricing Program; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Emergency Care Improvement Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
Emergency Care Improvement Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
Emergency Care Improvement Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
Emergency Care Improvement Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to 340B Drug Pricing Program; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Issues related to surprise billing; Issues related to telehealth; 1115 Medicaid Waiver; Issues related to the health care workforce; Issues related to maternal health; Freestanding ERs in relation to H.R. 1694 - Emergency Care Improvement Act; Implementation of H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments in relation to H.R. 2665 - The Supporting Safety Net Hospitals Act; Site-neutral payment policies in relation to H.R. 3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); S. 2840 - Bipartisan Primary Care and Health Workforce Act; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Emergency Care Improvement Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to 340B Drug Pricing Program; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Issues related to surprise billing; Issues related to telehealth; 1115 Medicaid Waiver; Issues related to the health care workforce; Issues related to maternal health; Freestanding ERs in relation to H.R. 1694 - Emergency Care Improvement Act; Implementation of H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments in relation to H.R. 2665 - The Supporting Safety Net Hospitals Act; Site-neutral payment policies in relation to H.R. 3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); S. 2840 - Bipartisan Primary Care and Health Workforce Act; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Emergency Care Improvement Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to 340B Drug Pricing Program; Rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Surprise billing; Telehealth; 1115 Medicaid Waiver; Health care workforce; Maternal health; Freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments (H.R. 2665 - The Supporting Safety Net Hospitals Act); Site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S. 2840 - Bipartisan Primary Care and Health Workforce Act); H.R. 3290 - 340B Drug Pricing Program; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Emergency Care Improvement Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
Fiscal Year 2025 Appropriations; Funding for recovery housing and substance use disorders (SUD); Expanding access to Medication-Assisted Treatment (MAT); Mental health and SUD legislation; H.R.4088/S.1991 - CAREER Act; H.R.2400 - Reentry Act of 2023; H.R.4531/S. 3393 - SUPPORT for Patients and Communities Reauthorization Act.
Choices for Stranded Passengers Act of 2023
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to 340B Drug Pricing Program; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Issues related to surprise billing; Issues related to telehealth; 1115 Medicaid Waiver; Issues related to the health care workforce; Issues related to maternal health; Freestanding ERs in relation to H.R. 1694 - Emergency Care Improvement Act; Implementation of H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments in relation to H.R. 2665 - The Supporting Safety Net Hospitals Act; Site-neutral payment policies in relation to H.R. 3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); S. 2840 - Bipartisan Primary Care and Health Workforce Act; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Choices for Stranded Passengers Act of 2023
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to 340B Drug Pricing Program; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Issues related to surprise billing; Issues related to telehealth; 1115 Medicaid Waiver; Issues related to the health care workforce; Issues related to maternal health; Freestanding ERs in relation to H.R. 1694 - Emergency Care Improvement Act; Implementation of H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments in relation to H.R. 2665 - The Supporting Safety Net Hospitals Act; Site-neutral payment policies in relation to H.R. 3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); S. 2840 - Bipartisan Primary Care and Health Workforce Act; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Choices for Stranded Passengers Act of 2023
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Children's Hospital GME funding; Implementation of H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. 117-328); FY 24 Appropriations.
Supporting Safety Net Hospitals Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to 340B Drug Pricing Program; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Issues related to surprise billing; Issues related to telehealth; 1115 Medicaid Waiver; Issues related to the health care workforce; Issues related to maternal health; Freestanding ERs in relation to H.R. 1694 - Emergency Care Improvement Act; Implementation of H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments in relation to H.R. 2665 - The Supporting Safety Net Hospitals Act; Site-neutral payment policies in relation to H.R. 3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); S. 2840 - Bipartisan Primary Care and Health Workforce Act; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Supporting Safety Net Hospitals Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
Supporting Safety Net Hospitals Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Surprise billing; Telehealth; 1115 Medicaid Waiver; Health care workforce; Maternal health; Freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments (H.R. 2665 - The Supporting Safety Net Hospitals Act); Site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S. 2840 - Bipartisan Primary Care and Health Workforce Act); H.R. 3290 - 340B Drug Pricing Program; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Supporting Safety Net Hospitals Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
Supporting Safety Net Hospitals Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
Supporting Safety Net Hospitals Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to 340B Drug Pricing Program; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Issues related to surprise billing; Issues related to telehealth; 1115 Medicaid Waiver; Issues related to the health care workforce; Issues related to maternal health; Freestanding ERs in relation to H.R. 1694 - Emergency Care Improvement Act; Implementation of H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments in relation to H.R. 2665 - The Supporting Safety Net Hospitals Act; Site-neutral payment policies in relation to H.R. 3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); S. 2840 - Bipartisan Primary Care and Health Workforce Act; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Supporting Safety Net Hospitals Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
Supporting Safety Net Hospitals Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to 340B Drug Pricing Program; Rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Surprise billing; Telehealth; 1115 Medicaid Waiver; Health care workforce; Maternal health; Freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments (H.R. 2665 - The Supporting Safety Net Hospitals Act); Site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S. 2840 - Bipartisan Primary Care and Health Workforce Act); H.R. 3290 - 340B Drug Pricing Program; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Drug Shortage Prevention Act of 2023
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
PAHPA reauthorization, including S.2333 - the Pandemic and All-Hazards Preparedness and Response Act and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; Pharmaceutical supply chain issues; H.R.6992/S.2364 - MAPS Act; H.R.3008 - Drug Shortage Prevention and Mitigation Act; Issues related to drug shortages.
Drug Shortage Prevention Act of 2023
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
PAHPA reauthorization, including S.2333 - the Pandemic and All-Hazards Preparedness and Response Act and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; Pharmaceutical supply chain issues; H.R.6992/S.2364 - MAPS Act; H.R.3008/S.2363 - Drug Shortage Prevention and Mitigation Act; S.5040 -Protecting Patients from Deceptive Drug Ads Online Act; Issues related to drug shortages.
Issues related to 340B Drug Pricing Program; Rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Surprise billing; Telehealth; 1115 Medicaid Waiver; Health care workforce; Maternal health; Freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments (H.R. 2665 - The Supporting Safety Net Hospitals Act); Site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S. 2840 - Bipartisan Primary Care and Health Workforce Act); H.R. 3290 - 340B Drug Pricing Program; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Surprise billing; Telehealth; 1115 Medicaid Waiver; Health care workforce; Maternal health; Freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments (H.R. 2665 - The Supporting Safety Net Hospitals Act); Site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S. 2840 - Bipartisan Primary Care and Health Workforce Act); H.R. 3290 - 340B Drug Pricing Program; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
Issues related to 340B Drug Pricing Program; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Issues related to surprise billing; Issues related to telehealth; 1115 Medicaid Waiver; Issues related to the health care workforce; Issues related to maternal health; Freestanding ERs in relation to H.R. 1694 - Emergency Care Improvement Act; Implementation of H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments in relation to H.R. 2665 - The Supporting Safety Net Hospitals Act; Site-neutral payment policies in relation to H.R. 3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); S. 2840 - Bipartisan Primary Care and Health Workforce Act; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Issues related to 340B Drug Pricing Program; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Issues related to surprise billing; Issues related to telehealth; 1115 Medicaid Waiver; Issues related to the health care workforce; Issues related to maternal health; Freestanding ERs in relation to H.R. 1694 - Emergency Care Improvement Act; Implementation of H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments in relation to H.R. 2665 - The Supporting Safety Net Hospitals Act; Site-neutral payment policies in relation to H.R. 3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); S. 2840 - Bipartisan Primary Care and Health Workforce Act; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
Issues related to 340B Drug Pricing Program; Rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Surprise billing; Telehealth; 1115 Medicaid Waiver; Health care workforce; Maternal health; Freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments (H.R. 2665 - The Supporting Safety Net Hospitals Act); Site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S. 2840 - Bipartisan Primary Care and Health Workforce Act); H.R. 3290 - 340B Drug Pricing Program; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Surprise billing; Telehealth; 1115 Medicaid Waiver; Health care workforce; Maternal health; Freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments (H.R. 2665 - The Supporting Safety Net Hospitals Act); Site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S. 2840 - Bipartisan Primary Care and Health Workforce Act); H.R. 3290 - 340B Drug Pricing Program; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Fiscal Year 2025 Appropriations; Funding for recovery housing and substance use disorders (SUD); Expanding access to Medication-Assisted Treatment (MAT); Mental health and SUD legislation; H.R.4088/S.1991 - CAREER Act; H.R.2400 - Reentry Act of 2023; H.R.4531/S. 3393 - SUPPORT for Patients and Communities Reauthorization Act.
Preparedness and Response Reauthorization Act
Client: UNIVERSITY OF LOUISVILLE · Firm: AKIN GUMP STRAUSS HAUER & FELD
FY 2024 and 2025 Appropriations, including Regional Biocontainment Laboratories (RBLs), PAHPA reauthorization, and S.2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R.4420 - Preparedness and Response Reauthorization Act; H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; S.4667 - Risky Research Review Act.
Preparing for All Hazards and Pathogens Reauthorization Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
PAHPA reauthorization (S. 2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act); Pharmaceutical supply chain issues, S. 2364 - Mapping America's Pharmaceutical Supply Act; S.2589 - Drug Shortage Prevention and Quality Improvement Act.
Preparing for All Hazards and Pathogens Reauthorization Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
PAHPA reauthorization (S. 2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act); Pharmaceutical supply chain issues, S. 2364 - Mapping America's Pharmaceutical Supply Act; drug shortages.
Preparing for All Hazards and Pathogens Reauthorization Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
PAHPA reauthorization, including S.2333 - the Pandemic and All-Hazards Preparedness and Response Act and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; Pharmaceutical supply chain issues; H.R.6992/S.2364 - MAPS Act; H.R.3008/S.2363 - Drug Shortage Prevention and Mitigation Act; S.5040 -Protecting Patients from Deceptive Drug Ads Online Act; Issues related to drug shortages.
Preparing for All Hazards and Pathogens Reauthorization Act
Client: UNIVERSITY OF LOUISVILLE · Firm: AKIN GUMP STRAUSS HAUER & FELD
FY 2024 and 2025 Appropriations, including Regional Biocontainment Laboratories (RBLs), PAHPA reauthorization, and S.2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R.4420 - Preparedness and Response Reauthorization Act; H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; S.4667 - Risky Research Review Act.
Preparing for All Hazards and Pathogens Reauthorization Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
PAHPA reauthorization, including S.2333 - the Pandemic and All-Hazards Preparedness and Response Act and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; Pharmaceutical supply chain issues; H.R.6992/S.2364 - MAPS Act; H.R.3008 - Drug Shortage Prevention and Mitigation Act; Issues related to drug shortages.
Support for Patients and Communities Reauthorization Act
Client: FLETCHER GROUP, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Fiscal Year 2025 Appropriations; Funding for recovery housing and substance use disorders (SUD); Expanding access to Medication-Assisted Treatment (MAT); Mental health and SUD legislation; H.R.4088/S.1991 - CAREER Act; H.R.2400 - Reentry Act of 2023; H.R.4531/S. 3393 - SUPPORT for Patients and Communities Reauthorization Act.
Women and Lung Cancer Research and Preventive Services Act of 2024
Client: QNOVIA, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues regarding smoking cessation; H.R. 4534/S.2245 - the Women and Lung Cancer Research and Preventive Services Act of 2023.
Women and Lung Cancer Research and Preventive Services Act of 2024
Client: QNOVIA, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues regarding smoking cessation; H.R. 4534 - the Women and Lung Cancer Research and Preventive Services Act of 2023.
Preserving Access to Home Health Act of 2023
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, legislative and regulatory proposals affecting home care and hospice; S. 100/ H.R. 547 - Better Care Better Jobs Act; S. 2137/H.R. 5159 - Preserving Access to Home Health Act of 2023; H.R. 8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Preserving Access to Home Health Act of 2023
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce; Legislative and regulatory proposals affecting home care and hospice; S. 100/H.R. 547 - Better Care Better Jobs Act; S. 2137/H.R. 5159 - Preserving Access to Home Health Act of 2023; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Preserving Access to Home Health Act of 2023
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce; Legislative and regulatory proposals affecting home care and hospice, including S. 100/H.R. 547 - the Better Care Better Jobs Act; S.2137/H.R.5159 - Preserving Access to Home Health Act of 2023; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Preserving Access to Home Health Act of 2023
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, and legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; H.R.8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Preserving Access to Home Health Act of 2023
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Lower Costs, More Transparency Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
Lower Costs, More Transparency Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to 340B Drug Pricing Program; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Issues related to surprise billing; Issues related to telehealth; 1115 Medicaid Waiver; Issues related to the health care workforce; Issues related to maternal health; Freestanding ERs in relation to H.R. 1694 - Emergency Care Improvement Act; Implementation of H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments in relation to H.R. 2665 - The Supporting Safety Net Hospitals Act; Site-neutral payment policies in relation to H.R. 3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); S. 2840 - Bipartisan Primary Care and Health Workforce Act; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Lower Costs, More Transparency Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to 340B Drug Pricing Program; Rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Surprise billing; Telehealth; 1115 Medicaid Waiver; Health care workforce; Maternal health; Freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments (H.R. 2665 - The Supporting Safety Net Hospitals Act); Site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S. 2840 - Bipartisan Primary Care and Health Workforce Act); H.R. 3290 - 340B Drug Pricing Program; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Lower Costs, More Transparency Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
Lower Costs, More Transparency Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
Lower Costs, More Transparency Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to 340B Drug Pricing Program; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Issues related to surprise billing; Issues related to telehealth; 1115 Medicaid Waiver; Issues related to the health care workforce; Issues related to maternal health; Freestanding ERs in relation to H.R. 1694 - Emergency Care Improvement Act; Implementation of H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments in relation to H.R. 2665 - The Supporting Safety Net Hospitals Act; Site-neutral payment policies in relation to H.R. 3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); S. 2840 - Bipartisan Primary Care and Health Workforce Act; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Lower Costs, More Transparency Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Surprise billing; Telehealth; 1115 Medicaid Waiver; Health care workforce; Maternal health; Freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments (H.R. 2665 - The Supporting Safety Net Hospitals Act); Site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S. 2840 - Bipartisan Primary Care and Health Workforce Act); H.R. 3290 - 340B Drug Pricing Program; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Lower Costs, More Transparency Act
Client: CHRISTUS HEALTH SYSTEM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
Better Care Better Jobs Act
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce; Legislative and regulatory proposals affecting home care and hospice, including S. 100/H.R. 547 - the Better Care Better Jobs Act; S.2137/H.R.5159 - Preserving Access to Home Health Act of 2023; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Better Care Better Jobs Act
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, legislative and regulatory proposals affecting home care and hospice; S. 100/ H.R. 547 - Better Care Better Jobs Act; S. 2137/H.R. 5159 - Preserving Access to Home Health Act of 2023; H.R. 8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Better Care Better Jobs Act
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce; Legislative and regulatory proposals affecting home care and hospice; S. 100/H.R. 547 - Better Care Better Jobs Act; S. 2137/H.R. 5159 - Preserving Access to Home Health Act of 2023; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Better Care Better Jobs Act
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Better Care Better Jobs Act
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, and legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; H.R.8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Connecting Our Medical Providers with Links to Expand Tailored and Effective Care Act
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Substance Use Disorder programs; S. 2433 - SUPPORT for Patients and Communities Reauthorization Act of 2023 funding; Issues related to behavioral health, including S. 1378/H.R. 5819 - COMPLETE Care Act; and S. 3059/H.R. 7708 - REAL Health Providers Act.
MAPS Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
PAHPA reauthorization, including S.2333 - the Pandemic and All-Hazards Preparedness and Response Act and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; Pharmaceutical supply chain issues; H.R.6992/S.2364 - MAPS Act; H.R.3008 - Drug Shortage Prevention and Mitigation Act; Issues related to drug shortages.
MAPS Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
PAHPA reauthorization, including S.2333 - the Pandemic and All-Hazards Preparedness and Response Act and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; Pharmaceutical supply chain issues; H.R.6992/S.2364 - MAPS Act; H.R.3008/S.2363 - Drug Shortage Prevention and Mitigation Act; S.5040 -Protecting Patients from Deceptive Drug Ads Online Act; Issues related to drug shortages.
To amend title XVIII of the Social Security Act to require MA organizations offering network-based plans to maintain an accurate provider directory, and for other purposes.
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Substance Use Disorder programs; S. 2433 - SUPPORT for Patients and Communities Reauthorization Act of 2023 funding; Issues related to behavioral health, including S. 1378/H.R. 5819 - COMPLETE Care Act; and S. 3059/H.R. 7708 - REAL Health Providers Act.
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
Client: UNIVERSITY OF LOUISVILLE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to funding for university research opportunities via fiscal year 2024 and fiscal year 2025 federal appropriations; H.R.8070/S.4638 - National Defense Authorization Act for Fiscal Year 2025; Issues related to Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, additive manufacturing.
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
Client: UNIVERSITY OF LOUISVILLE · Firm: AKIN GUMP STRAUSS HAUER & FELD
FY2025 Defense appropriations bill; H.R.8070/S.4638 - National Defense Authorization Act for Fiscal Year 2025; Issues related to cybersecurity, defense innovation, and military health.
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
Client: CENTRIENT PHARMACEUTICALS LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to health care supply chain and domestic pharmaceutical manufacturing; H.R.8070 - Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; S.4638 - National Defense Authorization Act for Fiscal Year 2025.
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
Client: UNIVERSITY OF LOUISVILLE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Cybersecurity research funding; implementation of the FY 2024 National Defense Authorization Act (PL 118-31), including Mission Acceleration Center and DCTC program; H.R.8070/S.4638 - FY 2025 National Defense Authorization Act.
To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, and legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; H.R.8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, legislative and regulatory proposals affecting home care and hospice; S. 100/ H.R. 547 - Better Care Better Jobs Act; S. 2137/H.R. 5159 - Preserving Access to Home Health Act of 2023; H.R. 8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Client: PARTNERSHIP FOR MEDICAID HOME-BASED CARE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to funding for Medicaid home and community-based services; Centers for Medicare and Medicaid Services Ensuring Access to Medicaid Services (CMS-2442-P) Proposed Rule; H.R. 8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Better Care Better Jobs Act
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Better Care Better Jobs Act
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce; Legislative and regulatory proposals affecting home care and hospice, including S. 100/H.R. 547 - the Better Care Better Jobs Act; S.2137/H.R.5159 - Preserving Access to Home Health Act of 2023; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Better Care Better Jobs Act
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, legislative and regulatory proposals affecting home care and hospice; S. 100/ H.R. 547 - Better Care Better Jobs Act; S. 2137/H.R. 5159 - Preserving Access to Home Health Act of 2023; H.R. 8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Better Care Better Jobs Act
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, and legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; H.R.8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Better Care Better Jobs Act
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce; Legislative and regulatory proposals affecting home care and hospice; S. 100/H.R. 547 - Better Care Better Jobs Act; S. 2137/H.R. 5159 - Preserving Access to Home Health Act of 2023; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Connecting Our Medical Providers with Links to Expand Tailored and Effective Care
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Substance Use Disorder programs; S. 2433 - SUPPORT for Patients and Communities Reauthorization Act of 2023 funding; Issues related to behavioral health, including S. 1378/H.R. 5819 - COMPLETE Care Act; and S. 3059/H.R. 7708 - REAL Health Providers Act.
Fiscal Year 2025 Appropriations; Funding for recovery housing and substance use disorders (SUD); Expanding access to Medication-Assisted Treatment (MAT); Mental health and SUD legislation; H.R.4088/S.1991 - CAREER Act; H.R.2400 - Reentry Act of 2023; H.R.4531/S. 3393 - SUPPORT for Patients and Communities Reauthorization Act.
Preserving Access to Home Health Act of 2023
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Preserving Access to Home Health Act of 2023
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce; Legislative and regulatory proposals affecting home care and hospice; S. 100/H.R. 547 - Better Care Better Jobs Act; S. 2137/H.R. 5159 - Preserving Access to Home Health Act of 2023; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Preserving Access to Home Health Act of 2023
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce; Legislative and regulatory proposals affecting home care and hospice, including S. 100/H.R. 547 - the Better Care Better Jobs Act; S.2137/H.R.5159 - Preserving Access to Home Health Act of 2023; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Preserving Access to Home Health Act of 2023
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, legislative and regulatory proposals affecting home care and hospice; S. 100/ H.R. 547 - Better Care Better Jobs Act; S. 2137/H.R. 5159 - Preserving Access to Home Health Act of 2023; H.R. 8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Preserving Access to Home Health Act of 2023
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, and legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; H.R.8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Women and Lung Cancer Research and Preventive Services Act of 2023
Client: QNOVIA, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues regarding smoking cessation; H.R. 4534/S.2245 - the Women and Lung Cancer Research and Preventive Services Act of 2023.
Pandemic and All-Hazards Preparedness and Response Act
Client: UNIVERSITY OF LOUISVILLE · Firm: AKIN GUMP STRAUSS HAUER & FELD
FY 2024 and 2025 Appropriations, including Regional Biocontainment Laboratories (RBLs), PAHPA reauthorization, and S.2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R.4420 - Preparedness and Response Reauthorization Act; H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; S.4667 - Risky Research Review Act.
Pandemic and All-Hazards Preparedness and Response Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
PAHPA reauthorization, including S.2333 - the Pandemic and All-Hazards Preparedness and Response Act and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; Pharmaceutical supply chain issues; H.R.6992/S.2364 - MAPS Act; H.R.3008 - Drug Shortage Prevention and Mitigation Act; Issues related to drug shortages.
Pandemic and All-Hazards Preparedness and Response Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
PAHPA reauthorization (S. 2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act); Pharmaceutical supply chain issues, S. 2364 - Mapping America's Pharmaceutical Supply Act; drug shortages.
Pandemic and All-Hazards Preparedness and Response Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
PAHPA reauthorization (S. 2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act); Pharmaceutical supply chain issues, S. 2364 - Mapping America's Pharmaceutical Supply Act; S.2589 - Drug Shortage Prevention and Quality Improvement Act.
Pandemic and All-Hazards Preparedness and Response Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
PAHPA reauthorization, including S.2333 - the Pandemic and All-Hazards Preparedness and Response Act and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; Pharmaceutical supply chain issues; H.R.6992/S.2364 - MAPS Act; H.R.3008/S.2363 - Drug Shortage Prevention and Mitigation Act; S.5040 -Protecting Patients from Deceptive Drug Ads Online Act; Issues related to drug shortages.
Youth Apprenticeship Advancement Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
PAHPA reauthorization, including S.2333 - the Pandemic and All-Hazards Preparedness and Response Act and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; Pharmaceutical supply chain issues; H.R.6992/S.2364 - MAPS Act; H.R.3008/S.2363 - Drug Shortage Prevention and Mitigation Act; S.5040 -Protecting Patients from Deceptive Drug Ads Online Act; Issues related to drug shortages.
MAPS Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
PAHPA reauthorization, including S.2333 - the Pandemic and All-Hazards Preparedness and Response Act and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; Pharmaceutical supply chain issues; H.R.6992/S.2364 - MAPS Act; H.R.3008/S.2363 - Drug Shortage Prevention and Mitigation Act; S.5040 -Protecting Patients from Deceptive Drug Ads Online Act; Issues related to drug shortages.
MAPS Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
PAHPA reauthorization (S. 2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act); Pharmaceutical supply chain issues, S. 2364 - Mapping America's Pharmaceutical Supply Act; S.2589 - Drug Shortage Prevention and Quality Improvement Act.
MAPS Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
PAHPA reauthorization, including S.2333 - the Pandemic and All-Hazards Preparedness and Response Act and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; Pharmaceutical supply chain issues; H.R.6992/S.2364 - MAPS Act; H.R.3008 - Drug Shortage Prevention and Mitigation Act; Issues related to drug shortages.
Issues related to Medicaid; Issues related NIH funding; Issues related to regional biocontainment laboratories; Issues related to precision medicine.
Issues related to flash flood preparedness.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOLLY HILL CHILDRENS HOME INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to appropriations to support mental health treatment and programs and services for victims of sexual trafficking.
Filing targets: SENATE
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to advanced manufacturing, drug shortages, and pharmaceutical supply chains; Issues related to S.1784 - MAPS Act.
Issues related to pharmaceutical supply chains, drug quality, and drug testing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FLETCHER GROUP, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to substance use disorder; Issues related to recovery housing; Issues related to Medicaid; H.R. 2483/S. 2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS ASSOCIATION FOR HOME CARE & HOSPICE via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, legislative and regulatory proposals affecting home care and hospice.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Children's Hospital GME funding; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Fiscal Year 2026 Appropriations.
Issues related to Medicaid, hospital reimbursement, Children's Hospital GME, Disproportionate Share Hospital (DSH) payments, and site-neutral payment, rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to telehealth; Issues related to health care workforce.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to Medicare Advantage compensation, agent and broker policies.
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
ALLIANCE FOR AGING RESEARCH via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to utilization management and changes to Medicare Part D.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKEUS PHARMACEUTICALS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to Stargardt disease and rare disease therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHATTERPROOF via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to Substance Use Disorder programs; SUPPORT Act reauthorization; Issues related to behavioral health; H.R. 7708/S. 3059 - REAL Health Providers Act (118th Congress).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to the Pandemic and All-Hazards Preparedness Act (P.L. 109-417)(PAHPA) reauthorization; Issues related to the pharmaceutical supply chain, drug shortages, advanced manufacturing, and pharmaceutical standards.
Issues related to pharmaceutical supply chains, drug quality, and drug testing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UOFL HEALTH, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to Medicaid funding.
Issues related to Medicaid funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF LOUISVILLE via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to funding for university research opportunities via Fiscal Year 2025 and 2026 federal appropriations; Fiscal Year 2026 defense authorization bill; Issues related to Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, and additive manufacturing.
Issues related to Fiscal Year 2025 and Fiscal Year 2026 Defense appropriations bill; Fiscal Year 2026 National Defense Authorization Act; Issues related to cybersecurity, defense innovation, and military health.
Issues related to funding for university research opportunities via Fiscal Year 2025 and Fiscal Year 2026 Federal appropriations; Fiscal Year 2026 defense authorization bill; Issues related to Regional Biocontainment Laboratories (RBLs), cybersecurity, and military health; H.R. 1864 / S. 854 - Risky Research Review Act.
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Children's Hospital GME funding; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Fiscal Year 2024 Appropriations.
Issues related to Medicaid, hospital reimbursement, Children's Hospital GME, Disproportionate Share Hospital (DSH) payments, and site-neutral payment.
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, Surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs.
FLETCHER GROUP, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to FY 2026 Appropriations; funding for recovery housing and substance use disorders (SUDs); Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QNOVIA, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues regarding smoking cessation; FY26 appropriations bill reports for Labor-HHS and Ag-FDA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues pertaining to Medicare Advantage compensation, agent and broker policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AGING RESEARCH via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to utilization management and changes to Medicare Part D.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKEUS PHARMACEUTICALS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to Stargardt disease and rare disease therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE SPEED ART MUSEUM via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · RR
Issues related to federal support for transportation safety project.
HOLLY HILL CHILDRENS HOME INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · RR
Issues related to Fiscal Year 2026 Appropriations.
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2024 · fourth_quarter · Q4
PAHPA reauthorization, including S.2333 - the Pandemic and All-Hazards Preparedness and Response Act and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; Pharmaceutical supply chain issues; H.R.6992/S.2364 - MAPS Act; H.R.3008 - Drug Shortage Prevention and Mitigation Act; Issues related to drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2024 · fourth_quarter · Q4
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
UNIVERSITY OF LOUISVILLE via AKIN GUMP STRAUSS HAUER & FELD
2024 · fourth_quarter · Q4
FY 2024 and 2025 Appropriations, including Regional Biocontainment Laboratories (RBLs), PAHPA reauthorization, and S.2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R.4420 - Preparedness and Response Reauthorization Act; H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; S.4667 - Risky Research Review Act.
FY2025 Defense appropriations bill; H.R.8070/S.4638 - National Defense Authorization Act for Fiscal Year 2025; Issues related to cybersecurity, defense innovation, and military health.
Issues related to funding for university research opportunities via fiscal year 2024 and fiscal year 2025 federal appropriations; H.R.8070/S.4638 - National Defense Authorization Act for Fiscal Year 2025; Issues related to Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, additive manufacturing.
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2024 · fourth_quarter · Q4
Issues pertaining to Medicare Advantage compensation, agent, and broker policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AGING RESEARCH via AKIN GUMP STRAUSS HAUER & FELD
2024 · fourth_quarter · Q4
Issues related to utilization management and changes to Medicare Part D.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALKEUS PHARMACEUTICALS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2024 · fourth_quarter · Q4
Issues related to Stargardt disease and rare disease therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF LOUISVILLE via AKIN GUMP STRAUSS HAUER & FELD
2024 · third_quarter · Q3
Issues related to funding for university research opportunities via FY 2024 and 2025 federal appropriations, FY 2025 defense authorization bill, Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, additive manufacturing.
Cybersecurity research funding; implementation of the FY 2024 National Defense Authorization Act (PL 118-31), including Mission Acceleration Center and DCTC program; H.R.8070/S.4638 - FY 2025 National Defense Authorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FLETCHER GROUP, INC. via AKIN GUMP STRAUSS HAUER & FELD
2024 · third_quarter · Q3
Fiscal Year 2025 Appropriations; Funding for recovery housing and substance use disorders (SUD); Expanding access to Medication-Assisted Treatment (MAT); Mental health and SUD legislation; H.R.4088/S.1991 - CAREER Act; H.R.2400 - Reentry Act of 2023; H.R.4531/S. 3393 - SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENTRIENT PHARMACEUTICALS LLC via AKIN GUMP STRAUSS HAUER & FELD
2024 · third_quarter · Q3
Issues related to health care supply chain and domestic pharmaceutical manufacturing; H.R.8070 - Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; S.4638 - National Defense Authorization Act for Fiscal Year 2025.
Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.
Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE
TEXAS ASSOCIATION FOR HOME CARE & HOSPICE via AKIN GUMP STRAUSS HAUER & FELD
2024 · third_quarter · Q3
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, and legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; H.R.8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2024 · third_quarter · Q3
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs; H.R.1694 - Emergency Care Improvement Act; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments; H.R.2665 - Supporting Safety Net Hospitals Act; Site-neutral payment policies; H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023.
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2024 · third_quarter · Q3
Issues related to the pharmaceutical industry supply chain, drug quality, and drug testing.
PAHPA reauthorization, including S.2333 - the Pandemic and All-Hazards Preparedness and Response Act and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; Pharmaceutical supply chain issues; H.R.6992/S.2364 - MAPS Act; H.R.3008/S.2363 - Drug Shortage Prevention and Mitigation Act; S.5040 -Protecting Patients from Deceptive Drug Ads Online Act; Issues related to drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2024 · third_quarter · Q3
Issues pertaining to Medicare Advantage compensation policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AGING RESEARCH via AKIN GUMP STRAUSS HAUER & FELD
2024 · third_quarter · Q3
Issues related to utilization management and changes to Medicare Part D, aging issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKEUS PHARMACEUTICALS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2024 · third_quarter · Q3
Issues related to Stargardt disease and rare disease therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2024 · second_quarter · Q2
Pharmaceutical and supply chain; drug quality and drug testing.
PAHPA reauthorization (S. 2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act); Pharmaceutical supply chain issues, S. 2364 - Mapping America's Pharmaceutical Supply Act; S.2589 - Drug Shortage Prevention and Quality Improvement Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS ASSOCIATION FOR HOME CARE & HOSPICE via AKIN GUMP STRAUSS HAUER & FELD
2024 · second_quarter · Q2
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, legislative and regulatory proposals affecting home care and hospice; S. 100/ H.R. 547 - Better Care Better Jobs Act; S. 2137/H.R. 5159 - Preserving Access to Home Health Act of 2023; H.R. 8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce; Legislative and regulatory proposals affecting home care and hospice; S. 100/H.R. 547 - Better Care Better Jobs Act; S. 2137/H.R. 5159 - Preserving Access to Home Health Act of 2023; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
QNOVIA, INC. via AKIN GUMP STRAUSS HAUER & FELD
2024 · second_quarter · Q2
Issues regarding smoking cessation; H.R. 4534 - the Women and Lung Cancer Research and Preventive Services Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR MEDICAID HOME-BASED CARE via AKIN GUMP STRAUSS HAUER & FELD
2024 · second_quarter · Q2
Issues related to funding for Medicaid home and community-based services; Centers for Medicare and Medicaid Services Ensuring Access to Medicaid Services (CMS-2442-P) Proposed Rule; H.R. 8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2024 · second_quarter · Q2
Issues pertaining to Medicare Advantage compensation policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AGING RESEARCH via AKIN GUMP STRAUSS HAUER & FELD
2024 · second_quarter · Q2
Issues related to utilization management and changes to Medicare Part D.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKEUS PHARMACEUTICALS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2024 · second_quarter · Q2
Issues related to Stargardt disease and rare disease therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2024 · second_quarter · Q2
Issues related to 340B Drug Pricing Program; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Issues related to surprise billing; Issues related to telehealth; 1115 Medicaid Waiver; Issues related to the health care workforce; Issues related to maternal health; Freestanding ERs in relation to H.R. 1694 - Emergency Care Improvement Act; Implementation of H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments in relation to H.R. 2665 - The Supporting Safety Net Hospitals Act; Site-neutral payment policies in relation to H.R. 3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); S. 2840 - Bipartisan Primary Care and Health Workforce Act; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Children's Hospital GME funding; Implementation of H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. 117-328); FY 24 Appropriations.
CENTRIENT PHARMACEUTICALS LLC via AKIN GUMP STRAUSS HAUER & FELD
2024 · second_quarter · Q2
Issues related to FY25 Labor-HHS and FY25 Defense appropriations bills and onshoring pharmaceutical supply chains.
Issues related to health care supply chain, domestic pharmaceutical manufacturing, and FY25 National Defense Authorization Act.
Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FUJIFILM HOLDINGS AMERICA CORPORATION via AKIN GUMP STRAUSS HAUER & FELD
2024 · second_quarter · Q2
Issues regarding domestic pharmaceutical manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKEUS PHARMACEUTICALS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2024 · second_quarter · RR
Issues related to the development of rare disease therapies.
TEXAS ASSOCIATION FOR HOME CARE & HOSPICE via AKIN GUMP STRAUSS HAUER & FELD
2024 · first_quarter · Q1
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce; Legislative and regulatory proposals affecting home care and hospice, including S. 100/H.R. 547 - the Better Care Better Jobs Act; S.2137/H.R.5159 - Preserving Access to Home Health Act of 2023; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2024 · first_quarter · Q1
Issues related to 340B Drug Pricing Program; Rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Surprise billing; Telehealth; 1115 Medicaid Waiver; Health care workforce; Maternal health; Freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments (H.R. 2665 - The Supporting Safety Net Hospitals Act); Site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S. 2840 - Bipartisan Primary Care and Health Workforce Act); H.R. 3290 - 340B Drug Pricing Program; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Surprise billing; Telehealth; 1115 Medicaid Waiver; Health care workforce; Maternal health; Freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments (H.R. 2665 - The Supporting Safety Net Hospitals Act); Site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S. 2840 - Bipartisan Primary Care and Health Workforce Act); H.R. 3290 - 340B Drug Pricing Program; and S. 3430 - The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
SHATTERPROOF via AKIN GUMP STRAUSS HAUER & FELD
2024 · first_quarter · Q1
Issues related to Substance Use Disorder programs; S. 2433 - SUPPORT for Patients and Communities Reauthorization Act of 2023 funding; Issues related to behavioral health, including S. 1378/H.R. 5819 - COMPLETE Care Act; and S. 3059/H.R. 7708 - REAL Health Providers Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENTRIENT PHARMACEUTICALS LLC via AKIN GUMP STRAUSS HAUER & FELD
2024 · first_quarter · Q1
Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.
Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) via AKIN GUMP STRAUSS HAUER & FELD
2024 · first_quarter · Q1
Issues related to medical device remanufacturing.
Issues related to cancer care and treatment, medical device remanufacturing, and AI use in health care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2024 · first_quarter · Q1
PAHPA reauthorization (S. 2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act); Pharmaceutical supply chain issues, S. 2364 - Mapping America's Pharmaceutical Supply Act; drug shortages.
Issues related to drug quality testing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QNOVIA, INC. via AKIN GUMP STRAUSS HAUER & FELD
2024 · first_quarter · Q1
Issues regarding smoking cessation; H.R. 4534/S.2245 - the Women and Lung Cancer Research and Preventive Services Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FUJIFILM HOLDINGS AMERICA CORPORATION via AKIN GUMP STRAUSS HAUER & FELD
2024 · first_quarter · Q1
Issues regarding domestic pharmaceutical manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2024 · first_quarter · Q1
Issues pertaining to Medicare Advantage compensation policies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR AGING RESEARCH via AKIN GUMP STRAUSS HAUER & FELD
2024 · first_quarter · Q1
Issues related to utilization management and changes to Medicare Part D.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AGING RESEARCH via AKIN GUMP STRAUSS HAUER & FELD
2024 · first_quarter · RR
Strengthen prescription drug utilization management protections for Medicare beneficiaries.
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; hospital reimbursement, including sequestration; prescription drug pricing; Surprise billing; telehealth; 1115 Medicaid Waiver; health care workforce; maternal health; freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments (H.R. 2665 - The Supporting Safety Net Hospitals Act); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act; S. 2840 - Bipartisan Primary Care and Health Workforce Act); and 340B Drug Pricing Program (H.R. 3290); and The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (S.3430).
Children's Hospital GME funding; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); FY 24 Appropriations.
INARI MEDICAL via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · 4T
Education and awareness of medical device treatments for blood clots.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENTRIENT PHARMACEUTICALS LLC via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.
Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MAINSTAY MEDICAL, LTD. via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
Medical device coverage and access; Private insurance coverage of peripheral nerve stimulation.
Issues related to reimbursement of medical devices for pain management; Medicare coverage of peripheral nerve stimulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
PAHPA reauthorization (S. 2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act), pharmaceutical supply chain issues, S. 2364 - Mapping America's Pharmaceutical Supply Act, drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QNOVIA, INC. via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
Advocacy issues related to smoking cessation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR MEDICAID HOME-BASED CARE via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
Issues related to funding for Medicaid home and community-based services, Centers for Medicare and Medicaid Services Ensuring Access to Medicaid Services (CMS-2442-P) Proposed Rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MILLENNIUM HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · 4T
Coverage of laboratory drug testing services, opioid crisis.
Coverage of laboratory drug testing services, opioid crisis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FUJIFILM HOLDINGS AMERICA CORPORATION via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · RR
Support for biopharmaceutical manufacturing in the U.S.
TEXAS ASSOCIATION FOR HOME CARE & HOSPICE via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce. Legislative and regulatory proposals affecting home care and hospice, including S. 100/H.R. 547 - Better Care Better Jobs Act; implementation of the Consolidated Appropriations Act, 2023 (PL 117-328); and S. 2137/H.R. 5128/H.R. 5159 - Preserving Access to Home Health Act of 2023.
Issues related to home care and hospice, telehealth, Medicare reimbursement. Legislative and regulatory proposals affecting home care and hospice.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Children's Hospital GME funding; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); FY 24 Appropriations.
Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; hospital reimbursement, including sequestration; prescription drug pricing; Surprise billing; telehealth; 1115 Medicaid Waiver; health care workforce; maternal health; Texas 1115 Medicaid waiver; freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
PAHPA reauthorization (S. 2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act), pharmaceutical supply chain issues, S. 2364 - Mapping America's Pharmaceutical Supply Act, drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RESMED CORP. via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Issues regarding Medicare reimbursement for respiratory devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR MEDICAID HOME-BASED CARE via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Medicaid home- and community-based services funding; Issues related to funding for Medicaid home and community-based services, alignment of Medicare and Medicaid Programs to protect the dually eligible population, the definition of private duty nursing, and section 409 of H.R. 6000 - Cures 2.0 Act. Centers for Medicare and Medicaid Services Ensuring Access to Medicaid Services (CMS-2442-P) Proposed Rule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MILLENNIUM HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Medicare and Medicaid coverage and reimbursement of laboratory tests; Data analytics to inform policy making.
Issues related to opioids/substance use; Issues impacting toxicology testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MAINSTAY MEDICAL, LTD. via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Medical device coverage and access.
Issues related to reimbursement of medical devices for pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INARI MEDICAL via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Education and awareness of medical device treatments for blood clots.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Supply chain issues; advanced manufacturing; drug shortages; cannabis; compounding.
PAHPA reauthorization; pharmaceutical supply chain issues; advanced manufacturing; cannabis; drug shortages; compounding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; hospital reimbursement, including sequestration; prescription drug pricing; Surprise billing; telehealth; 1115 Medicaid Waiver; health care workforce; maternal health; Texas 1115 Medicaid waiver; freestanding ERs (H.R. 1694); implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).
Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; hospital reimbursement, including sequestration; prescription drug pricing; Surprise billing; telehealth; 1115 Medicaid Waiver; health care workforce; maternal health; Texas 1115 Medicaid waiver; freestanding ERs (H.R. 1694); implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).
SENSEONICS INCORPORATED via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Issues relates to Medicare reimbursement for an implantable device; Issues relating to Medicare Physician Fee Schedule (PFS).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
MILLENNIUM HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Opioids/substance use; Issues impacting laboratories; telehealth.
Medicare and Medicaid coverage and reimbursement of laboratory tests; Data analytics to inform policy making.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MAINSTAY MEDICAL, LTD. via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Issues related to reimbursement of medical devices for pain management.
Medical device coverage and access.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MAINSTAY MEDICAL, LTD. via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Issues related to reimbursement of medical devices for pain management.
Medical device coverage and access.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INARI MEDICAL via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Education and awareness of medical device treatments for blood clots.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRADLEY LANE INVESTMENT COMPANY via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
ARPA-H location.
ARPA-H location.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CENTRIENT PHARMACEUTICALS LLC via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Issues related to onshoring supply chains and manufacturing of essential medicines to the United States.
Issues related to onshoring supply chains and manufacturing of essential medicines to the United States.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Science & Technology Policy (OSTP), SENATE, White House Office
BRADLEY LANE INVESTMENT COMPANY via AKIN GUMP STRAUSS HAUER & FELD
2023 · first_quarter · Q1
ARPA-H location.
ARPA-H location.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CENTRIENT PHARMACEUTICALS LLC via AKIN GUMP STRAUSS HAUER & FELD
2023 · first_quarter · Q1
Issues related to onshoring supply chains and manufacturing of essential medicines to the United States.
Issues related to onshoring supply chains and manufacturing of essential medicines to the United States.
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), SENATE, White House Office
TEXAS ASSOCIATION FOR HOME CARE & HOSPICE via AKIN GUMP STRAUSS HAUER & FELD
2023 · first_quarter · Q1
Issues related to home care and hospice, telehealth, Medicare reimbursement. Legislative and regulatory proposals affecting home care and hospice. Better Care Better Jobs Act (S. 100/ H. R. 547).
Issues related to home care and hospice, telehealth, Medicare reimbursement. Legislative and regulatory proposals affecting home care and hospice. Better Care Better Jobs Act (S. 100/ H. R. 547).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2023 · first_quarter · Q1
Medical supply chain issues and supply chain integrity; advanced manufacturing; cannabis; compounding.
PAHPA reauthorization; pharmaceutical supply chain issues; advanced manufacturing; cannabis; compounding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MILLENNIUM HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2023 · first_quarter · Q1
Medicare and Medicaid coverage and reimbursement of laboratory tests; Data analytics to inform policy making.
Opioids/substance use; Issues impacting laboratories; telehealth.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MAINSTAY MEDICAL, LTD. via AKIN GUMP STRAUSS HAUER & FELD
2023 · first_quarter · Q1
Issues related to reimbursement of medical devices for pain management.
Medical device coverage and access.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CENTRIENT PHARMACEUTICALS LLC via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · 4A
Issues related to onshoring supply chains and manufacturing of essential medicines to the United States.
Issues related to onshoring supply chains and manufacturing of essential medicines to the United States.
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, White House Office
CENTRIENT PHARMACEUTICALS LLC via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · Q4
Issues related to onshoring supply chains and manufacturing of essential medicines to the United States.
Issues related to onshoring supply chains and manufacturing of essential medicines to the United States.
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, White House Office
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · Q4
COVID-19 pandemic response and Provider Relief Fund; Supply chain reform; American Rescue Plan Act (P.L. 117-2); Health insurance exchange regulations; Health insurance reform; Health information technology and telehealth funding; 340B Drug Pricing Program and prescription drug pricing; Surprise billing; Maternal and child health; Dr. Lorna Breen Health Care Provider Protection Act (H.R. 1667); Telehealth; Health care workforce; Rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Section 1115 Medicaid waiver; Issues related to 340B Drug Pricing Program; prescription drug pricing; the Provider Relief Fund; COVID relief; 1115 Medicaid Waiver; maternal health; freestanding ERs; the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); Medicare sequestration; hospital reimbursement; rural health; 340B Drug Pricing Program.
COVID-19 pandemic response and Provider Relief Fund; Supply chain reform; American Rescue Plan Act (P.L. 117-2); Health insurance exchange regulations; Health insurance reform; Health information technology and telehealth funding; 340B Drug Pricing Program and prescription drug pricing; Surprise billing; Maternal and child health; Dr. Lorna Breen Health Care Provider Protection Act (H.R. 1667); Telehealth; Health care workforce; Rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Section 1115 Medicaid Waiver; Issues related to 340B Drug Pricing Program; prescription drug pricing; the Provider Relief Fund; COVID relief; 1115 Medicaid Waiver; maternal health; the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328).; Hospital reimbursement; rural health; 340B Drug Pricing Program.
PARTNERSHIP FOR MEDICAID HOME-BASED CARE via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · Q4
H.R. 5376 (Medicaid home- and community-based services funding); H.R. 6000, Cures 2.0 Act (Section 409); alignment of Medicaid and Medicare programs for dual eligible populations to improve care; presumptive eligibility for Medicaid HCBS; establishment of a federal definition of private duty nursing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · Q4
Medical supply chain issues and supply chain integrity; advanced manufacturing; cannabis.
Medical supply chain issues and supply chain integrity; advanced manufacturing; cannabis.
Filing targets: HOUSE OF REPRESENTATIVES
BRADLEY LANE INVESTMENT COMPANY via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · Q4
ARPA-H location.
ARPA-H location.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
MILLENNIUM HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · Q4
Opioids/substance use; Issues impacting laboratories; telehealth
Medicare and Medicaid coverage and reimbursement of laboratory tests; Data analytics to inform policy making; COVID-19 relief and response initiatives.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MAINSTAY MEDICAL, LTD. via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · Q4
Medical device coverage and access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INARI MEDICAL via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · Q4
Education and awareness of medical device treatments for blood clots.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FINTHRIVE, INC. via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · Q4
Social Determinants Accelerator Act of 2021 (S. 3039 / H.R. 2503).
Filing targets: SENATE
Issues related to flash flood preparedness.
Issues related to funding for university research opportunities via Fiscal Year 2025 and Fiscal Year 2026 Federal appropriations; Fiscal Year 2026 defense authorization bill; Issues related to Regional Biocontainment Laboratories (RBLs), cybersecurity, and military health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Children's Hospital GME funding; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Fiscal Year 2024 Appropriations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Children's Hospital GME funding; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); FY 24 Appropriations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to 340B Drug Pricing Program; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Hospital reimbursement, including sequestration; Prescription drug pricing; Issues related to surprise billing; Issues related to telehealth; 1115 Medicaid Waiver; Issues related to the health care workforce; Issues related to maternal health; Freestanding ERs in relation to H.R. 1694 - Emergency Care Improvement Act; Implementation of H.R. 2617 - Consolidated Appropriations Act of 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments in relation to H.R. 2665 - The Supporting Safety Net Hospitals Act; Site-neutral payment policies in relation to H.R. 3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); S. 2840 - Bipartisan Primary Care and Health Workforce Act; S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Children's Hospital GME funding; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); FY 24 Appropriations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; hospital reimbursement, including sequestration; prescription drug pricing; Surprise billing; telehealth; 1115 Medicaid Waiver; health care workforce; maternal health; freestanding ERs (H.R. 1694); implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Disproportionate Share Hospital (DSH) payments (H.R. 2665 - The Supporting Safety Net Hospitals Act); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); S. 2840 - Bipartisan Primary Care and Health Workforce Act; 340B Drug Pricing Program (H.R. 3290); and The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (S.3430).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to 340B Drug Pricing Program; rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; hospital reimbursement, including sequestration; prescription drug pricing; Surprise billing; telehealth; 1115 Medicaid Waiver; health care workforce; maternal health; Texas 1115 Medicaid waiver; freestanding ERs (H.R. 1694 - Emergency Care Improvement Act); implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Children's Hospital GME funding; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); FY 24 Appropriations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE